Patrick McClymont - Net Worth and Insider Trading

Patrick McClymont Net Worth

The estimated net worth of Patrick McClymont is at least $109,164 dollars as of 2024-09-24. Patrick McClymont is the Senior Officer of Knight Therapeutics Inc and owns about 18,471 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $109,164. Details can be seen in Patrick McClymont's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Patrick McClymont has not made any transactions after 2019-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Patrick McClymont

To

Patrick McClymont Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Patrick McClymont owns 1 companies in total, including Knight Therapeutics Inc (TSX:GUD) .

Click here to see the complete history of Patrick McClymont’s form 4 insider trades.

Insider Ownership Summary of Patrick McClymont

Ticker Comapny Transaction Date Type of Owner
TSX:GUD Knight Therapeutics Inc 2019-08-09 Senior Officer

Patrick McClymont Latest Holdings Summary

Patrick McClymont currently owns a total of 1 stock. Patrick McClymont owns 18,471 shares of Knight Therapeutics Inc (TSX:GUD) as of August 9, 2019, with a value of $109,164.

Latest Holdings of Patrick McClymont

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:GUD Knight Therapeutics Inc 2019-08-09 18,471 5.91 109,164

Holding Weightings of Patrick McClymont


Patrick McClymont Form 4 Trading Tracker

According to the SEC Form 4 filings, Patrick McClymont has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the sale of 1,915 shares on August 9, 2019, which brought Patrick McClymont around $55,907.

Insider Trading History of Patrick McClymont

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Patrick McClymont Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Patrick McClymont Ownership Network

Ownership Network List of Patrick McClymont

No Data

Ownership Network Relation of Patrick McClymont

Insider Network Chart

Patrick McClymont Owned Company Details

What does Knight Therapeutics Inc do?

Who are the key executives at Knight Therapeutics Inc?

Patrick McClymont is the Senior Officer of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .

Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary

Over the past 18 months, Patrick McClymont made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .

In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.

Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Knight Therapeutics Inc Insider Transactions

No Available Data

Patrick McClymont Mailing Address

Above is the net worth, insider trading, and ownership report for Patrick McClymont. Currently GuruFocus does not have mailing address information for Patrick McClymont.

Discussions on Patrick McClymont

No discussions yet.